Regulated information
June 2, 2023
Accor Acquisition Company will buy-back and cancel all the Market Shares on June 12, 2023
On June 2, 2023, the Board of Directors of Accor Acquisition Company ("AAC"
Skyepharma is a France-based CDMO with over 20 years of innovation and development expertise and a renowned player in the global biopharma and consumer health industries. The company's unique offer
Regulated information
April 27, 2023
Accor Acquisition Company announces its intention to liquidate after buying back all the Market Shares
The Company has closed its 2022 annual accounts and is making
Regulated information
April 27, 2023
Accor Acquisition Company announces its intention to liquidate after buying back all the Market Shares
The Company has closed its 2022 annual accounts and is. | April 27, 2023